Inayat Hussain Khan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Inayat Hussain Khan has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Tasnim Chowdhury
School of Medicine, Faculty of Life Sciences, St. George’s, University of London, Cranmer Terrace, London, SW17 0RE, UK
2 shared publications - Amer Harky
Liverpool Heart and Chest Hospital
1 shared publication - Azhar Ramzan Bilal
Faculty of Medicine, St George's Hospital Medical School, London, UK
1 shared publication - Samiul Oliver Khan
Faculty of Medicine, St George's Hospital Medical School, London, UK
1 shared publication - Sevim Zaim
Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK
1 shared publication - Syeda Anum Zahra
St Marys Hospital, Imperial College NHS Trust, Praed Street, Paddington, London W2 1NY, UK; Imperial College London, Exhibition Rd, South Kensington, London SW7 2BX, UK
1 shared publication
Latest Publications
- 5 May 2020
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 35 (6) , 1287-1294
At the heart of COVID‐19
Coronavirus disease (COVID‐19) first presented in Wuhan, Hubei province, China in December 2019. Since then, it has rapidly spread across the world, and is now formally considered a pandemic. The disease does not discriminate but increasing age and the presence of comorbidities are associated with severe form of the disease and poor outcomes. Although the prevalence of COVID‐19 in patients with cardiovascular disease is under‐reported, there is evidence that pre‐existing cardiac disease can render individuals vulnerable. It is thought that COVID‐19 may have both a direct and indirect effect on the cardiovascular system; however, the primary mechanism of underlying cardiovascular involvement is still uncertain. Of particular interest is the role of angiotensin‐converting enzyme 2, which is well known for its cardiovascular effects and is also considered to be important in the pathogenesis of COVID‐19. With a range of different drug candidates being suggested, effective anti‐virals and vaccines are an area of on‐going research. While our knowledge of COVID‐19 continues to rapidly expand, this review highlights recent advances in our understanding of the interaction between COVID‐19 and the cardiovascular system.
- 5 May 2020
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 35 (6) , 1287-1294
At the heart of COVID‐19
Coronavirus disease (COVID‐19) first presented in Wuhan, Hubei province, China in December 2019. Since then, it has rapidly spread across the world, and is now formally considered a pandemic. The disease does not discriminate but increasing age and the presence of comorbidities are associated with severe form of the disease and poor outcomes. Although the prevalence of COVID‐19 in patients with cardiovascular disease is under‐reported, there is evidence that pre‐existing cardiac disease can render individuals vulnerable. It is thought that COVID‐19 may have both a direct and indirect effect on the cardiovascular system; however, the primary mechanism of underlying cardiovascular involvement is still uncertain. Of particular interest is the role of angiotensin‐converting enzyme 2, which is well known for its cardiovascular effects and is also considered to be important in the pathogenesis of COVID‐19. With a range of different drug candidates being suggested, effective anti‐virals and vaccines are an area of on‐going research. While our knowledge of COVID‐19 continues to rapidly expand, this review highlights recent advances in our understanding of the interaction between COVID‐19 and the cardiovascular system.
- Open Access
- 1 January 2020
- Published by Taylor & Francis in Risk Management and Healthcare Policy
- Vol. ume 13, 3-4
Considering the Role of Psychological Stress on Sleep Quality in Individuals with Subclinical Hypothyroidism [Letter]
Considering the Role of Psychological Stress on Sleep Quality in Individuals with Subclinical Hypothyroidism [Letter] Inayat Hussain Khan, Tasnim Chowdhury, Samiul Oliver Khan Faculty of Medicine, St George’s Hospital Medical School, London, UKCorrespondence: Inayat Hussain KhanFaculty of Medicine, St George’s Hospital Medical School, Cranmer Terrace, London SW17 0RE, UKTel +44 20 8672 9944Email m1506131@sgul.ac.ukWe read the article by Song et al with great interest1 and thank the authors for exploring the relationship between subclinical hypothyroidism and sleep quality in a large general population. Subclinical hypothyroidism is a challenge to both patients and healthcare systems; potential sequelae include progression to hypothyroidism and cardiovascular disease.2 There are few studies exploring the relationship between subclinical hypothyroidism and sleep quality despite its extensive impact on health, as discussed in the current study.1 View the original paper by Song and colleagues
- 1 January 2020
- Published by Taylor & Francis in Risk Management and Healthcare Policy
- Vol. ume 13, 3-4
Open AccessConsidering the Role of Psychological Stress on Sleep Quality in Individuals with Subclinical Hypothyroidism [Letter]
Considering the Role of Psychological Stress on Sleep Quality in Individuals with Subclinical Hypothyroidism [Letter] Inayat Hussain Khan, Tasnim Chowdhury, Samiul Oliver Khan Faculty of Medicine, St George’s Hospital Medical School, London, UKCorrespondence: Inayat Hussain KhanFaculty of Medicine, St George’s Hospital Medical School, Cranmer Terrace, London SW17 0RE, UKTel +44 20 8672 9944Email m1506131@sgul.ac.ukWe read the article by Song et al with great interest1 and thank the authors for exploring the relationship between subclinical hypothyroidism and sleep quality in a large general population. Subclinical hypothyroidism is a challenge to both patients and healthcare systems; potential sequelae include progression to hypothyroidism and cardiovascular disease.2 There are few studies exploring the relationship between subclinical hypothyroidism and sleep quality despite its extensive impact on health, as discussed in the current study.1 View the original paper by Song and colleagues
- Open Access
- 1 August 2019
- Published by Taylor & Francis in Patient Preference and Adherence
- Vol. ume 13, 1335-1336
The role of technology in the management of Diabetes mellitus [Letter]
The role of technology in the management of Diabetes mellitus [Letter] Inayat Hussain Khan, Azhar Ramzan BilalFaculty of Medicine, St George’s Hospital Medical School, London, UK We read this article by Khurana et al1 with great interest. It is encouraging to see a study which explored how adherence in patients with Type 2 Diabetes mellitus could potentially be improved.Diabetes is a condition affecting an increasing number of people and the macrovascular and microvascular changes are damaging to long term health, predisposing to vascular events such as heart attacks and strokes.2 Adherence to treatment plans is essential for good glycaemic control and to prevent such complications. A study found that effective communication between doctors and patients is key to ensuring adherence to individual treatment plans but of course this does not always take place.3 This current study1 evaluated how technology can help to bridge this gap in the management of chronic conditions like diabetes where treatment is lifelong and complex. Khurana et al1 showed that there is an appetite amongst patients for better use of technology to help manage chronic conditions; more than 80% of the participants surveyed in this studywere interested in using electronic methods to assist them in managing their diabetes.
- 1 August 2019
- Published by Taylor & Francis in Patient Preference and Adherence
- Vol. ume 13, 1335-1336
Open AccessThe role of technology in the management of Diabetes mellitus [Letter]
The role of technology in the management of Diabetes mellitus [Letter] Inayat Hussain Khan, Azhar Ramzan BilalFaculty of Medicine, St George’s Hospital Medical School, London, UK We read this article by Khurana et al1 with great interest. It is encouraging to see a study which explored how adherence in patients with Type 2 Diabetes mellitus could potentially be improved.Diabetes is a condition affecting an increasing number of people and the macrovascular and microvascular changes are damaging to long term health, predisposing to vascular events such as heart attacks and strokes.2 Adherence to treatment plans is essential for good glycaemic control and to prevent such complications. A study found that effective communication between doctors and patients is key to ensuring adherence to individual treatment plans but of course this does not always take place.3 This current study1 evaluated how technology can help to bridge this gap in the management of chronic conditions like diabetes where treatment is lifelong and complex. Khurana et al1 showed that there is an appetite amongst patients for better use of technology to help manage chronic conditions; more than 80% of the participants surveyed in this studywere interested in using electronic methods to assist them in managing their diabetes.
- Open Access
- 1 January 2019
- Published by Taylor & Francis in Clinical Epidemiology
- Vol. ume 11, 125-126
Recognizing the role of psychiatric comorbidities: a response to the Danish Colorectal Screening Program
Recognizing the role of psychiatric comorbidities: a response to the Danish Colorectal Screening Program
- 1 January 2019
- Published by Taylor & Francis in Clinical Epidemiology
- Vol. ume 11, 125-126
Open AccessRecognizing the role of psychiatric comorbidities: a response to the Danish Colorectal Screening Program
Recognizing the role of psychiatric comorbidities: a response to the Danish Colorectal Screening Program